Cargando…
High levels of circulating osteopontin in inflammatory lung disease regardless of Sars‐CoV‐2 infection
This study independently confirms increased levels of osteopontin in COVID‐19 patients but also suggests that osteopontin cannot be used as a biomarker of SARS‐CoV‐2 infection, as elevated levels of circulating osteopontin are found in inflammatory lung disease regardless of SARS‐CoV‐2 infection.[Im...
Autores principales: | Cappellano, Giuseppe, Abreu, Hugo, Raineri, Davide, Scotti, Lorenza, Castello, Luigi, Vaschetto, Rosanna, Chiocchetti, Annalisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103078/ https://www.ncbi.nlm.nih.gov/pubmed/33787012 http://dx.doi.org/10.15252/emmm.202114124 |
Ejemplares similares
-
High levels of circulating osteopontin in inflammatory lung disease regardless of SARS‐CoV‐2 infection
por: Cappellano, Giuseppe, et al.
Publicado: (2021) -
Worse Disease Prognosis Is Associated to an Increase of Platelet-Derived Extracellular Vesicles in Hospitalized SARS-CoV-2 Patients
por: Raineri, Davide, et al.
Publicado: (2022) -
Circulating Platelet-Derived Extracellular Vesicles Are a Hallmark of Sars-Cov-2 Infection
por: Cappellano, Giuseppe, et al.
Publicado: (2021) -
Osteopontin at the Crossroads of Inflammation and Tumor Progression
por: Castello, Luigi Mario, et al.
Publicado: (2017) -
Osteopontin Bridging Innate and Adaptive Immunity in Autoimmune Diseases
por: Clemente, Nausicaa, et al.
Publicado: (2016)